POINT ROBERTS, Wash., May 7, 2009 www.BiotechIndustryStocks.com, a global investor website for the biotechnology sector within Investorideas.com, presents a biotech stocks sector close- up following sharp gains in Vanda Pharmaceuticals Inc. (NasdaqGM:VNDA), following news that the FDA approved Vanda Pharmaceuticals' Fanap for the treatment of Schizophrenia.
Other biotech stocks up on the day include Amgen Inc. (NasdaqGS: AMGN), Genzyme Corporation (NasdaqGS: GENZ) and Gilead Sciences, Inc. (NasdaqGS: GILD).
- Published: 07 May 2009
- Written by sandihop